Pathology, protein expression and signaling in myxomatous mitral valve degeneration: Comparison of dogs and humans

Journal of Veterinary Cardiology

Volumn 14, Issue 1, 2012, Pages 59-71

  Aupperle, Heike ^a   Disatian, Sirilak ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Canine; Collagen; Human; Matrix metalloproteinase; Mitral valve disease; Serotonin; Valve interstitial cells

Indexed keywords

COLLAGEN; MATRIX METALLOPROTEINASE; MESSENGER RNA; PROTEOGLYCAN; SEROTONIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; DEGENERATION; DISEASE COURSE; DISEASE SEVERITY; DOG; DOG DISEASE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HEART MUSCLE CELL; HEART MYXOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LYMPHOCYTE; MACROPHAGE; MITRAL VALVE DISEASE; MYXOMATOUS DEGENERATIVE MITRAL VALVE DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

CANIS FAMILIARIS;

EID: 84858447975     PISSN: 17602734     EISSN: 18750834     Source Type: Journal    
DOI: 10.1016/j.jvc.2012.01.005     Document Type: Review

References (110)

1. J.W. Buchanan Chronic valvular disease (endocardiosis) in dogs Adv Vet Sci Comp Med 21 1977 75 108
2. J. Häggström, H.D. Pedersen, and C. Kvart New insights into degenerative mitral valve disease in dogs Vet Clin North Am Small Anim Pract 34 2004 1209 1226
3. G. Trautwein, W. Brass, U. Kersten, E. ernst, P. Schneider, L.C. Schulz, G. Amtsberg, W. Bisping, H. Kirchhoff, and J. Schole Untersuchungen zur Ätiologie und Pathogenese der Endokardiose und Endokarditis des Hundes Dtsch Tierärztl Wochenschr 80 1973 507 511
4. S. Liu, and L.P. Tilley Malformation of the mitral valve complex J Am Vet Med Assoc 167 1975 465 471
5. K. Kogure Pathology of chronic mitral valvular disease in the dog Jpn J Vet Sci 42 1980 323 325
6. G.J. Jacobs, C.A. Calvert, M.B. Mahaffey, and D.G. Hall Echocardiographic detection of flail left atrioventricular valve cusp from ruptured chordae tendineae in 4 dogs J Vet Intern Med 9 1995 341 346
7. W.F. Robinson, and M.G. Maxie Endocardiosis in dogs K.V.F. Jubb, P.C. Kennedy, N. Palmer, The pathology of domestic animals vol 3 1993 Academic press San Diego, USA 23 24
8. J. Schole Untersuchungen zur Ätiologie und Pathogenese der Endokardiose und Endokarditis des Hundes. IV. Biochemische Untersuchungen Dtsch Tierärztl Wochenschr 80 1973 472 473
9. Häggström J. Chronic valvular disease in Cavalier King Charles Spaniels. Epidemiology, inheritance and pathophysiology. Thesis, Swedish University of Agricultural Sciences, Uppsala, Sweden, 1996.
10. S. Swift The problem of inherited diseases. 5: valvular disease in Cavalier King Charles Spaniels Vet Clin North Am Small Anim Pract 37 1996 505 506
11. L.H. Olsen, A. Kristensen, J. Häggström, A.L. Jensen, B. Klitgaard, H. Hansson, and H.D. Pedersen Increased platelet aggregation response in Cavalier King Charles Spaniel with mitral valve prolapse J Vet Intern Med 15 2001 209 216
12. C. Hyun Mitral valve prolapse in Cavalier King Charles Spaniel: a review and case study J Vet Sci 6 2005 67 73
13. L.H. Olsen, M. Fredholm, and H.D. Pederson Epidemiology and inheritance of mitral valve prolapse in Dachshunds J Vet Intern Med 13 1999 448 456
14. E. Ernst, P. Schneider, and G. Trautwein Die Endokardiose der Atrioventrikularklappen des Hundes IV: Elektronenmikroskopische Untersuchungen Zentralbl Vet Med A 21 1974 400 416
15. L.H. Olsen, K. Mortensen, T. Martinussen, L.I. Larsson, U. Baandrup, and H.D. Pedersen Increased NADPH-diaphorase activity in canine myxomatous mitral valve leaflets J Comp Pathol 129 2003 120 130
16. M.A. Oyama Quantification of mitral regurgitation volume and effective orifice area using the proximal isovelocity surface area (PISA) method Proc 1st Int Canine Valv Dis Symp 2004 pp. 43-47
17. Bonagura, JE, Schober, KE. Can ventricular function be assessed by echocardiography in chronic canine mitral valve disease? 2009;50(suppl 1):12-24.
18. P.M. Shah Current concepts in mitral valve prolapse - diagnosis and management J Cardiol 56 2010 125 133
19. B. Iung, and A. Vahanian Epidemiology of valvular heart disease in the adult Nat Rev Cardiol 8 2011 162 172
20. J.-F. Avierinos, J. Inamo, F. Grigioni, B. Gersh, C.S. Shub, and M. Enriquez-Sarano Sex differences in the morphology and outcomes of mitral valve prolapse: a cohort study Ann Intern Med 149 2008 787 795
21. M.R. Movahed, and A.D. Hepner Mitral valvular prolapse is significantly associated with low body mass index in addition to mitral and tricuspid regurgitation Cardiol Young 17 2007 172 174
22. Jacquet-Davis Mitral valve prolapse Prim Care Update Ob/Gyns 2 1995 1 5
23. D.E.L. Wilcken Genes, gender and geometry and prolapsing mitral valve Aust NZ J Med 22 1992 556 561
24. R.B. Deveroux, R. Kramer-Fox, and P. Kligfield Mitral valve prolapse: causes, clinical manifestations and management Ann Intern Med 111 1989 305 317
25. H. Boudoulas, A.J. Kolibash, P. Baker, B.D. King, and C.F. Wooley Mitral valve prolapse and the mitral valve prolapse syndrome: a diagnostic classification and pathogenesis of symptoms Am Heart J 118 1989 797 818
26. S.U. Sell, and R.E. Scully Aging changes in the aortic und mitral valves: histological and histochemical studies with observations on calcific aortic stenosis and calcification of the mitral annulus Am J Pathol 46 1965 345 365
27. P. Schneider, E. Ernst, and G. Trautwein Enzyme histocytochemical studies of atrioventricular heart valves in endocardiosis in the dog Vet Pathol 10 1973 281 294
28. B.M. Corcoran, A. Black, J. McEwan, A. French, P. Smith, and C. Devine Identification of surface morphologic changes in the mitral valve leaflets and chordae tendineae of dogs with myxomatous degeneration Am J Vet Res 65 2004 198 206
29. A. Black, A.T. French, J. Dukes-McEwan, and B.M. Corcoran Ultrastructural morphologic evaluation of the phenotype of valvular interstitial cells in dogs with myxomatous degeneration of the mitral valve Am J Vet Res 66 2005 1408 1414
30. S. Disatian, E.J. Ehrhart III, S. Zimmerman, and E.C. Orton Interstitial cells from dogs with naturally-occurring myxomatous mitral valve disease undergo phenotype transformation J Heart Valve Dis 17 4 2008 402 412
31. H. Aupperle, I. März, J. Thielebein, B. Kiefer, A. Kappe, and H.A. Schoon Immunohistochemical characterization of the extracellular matrix in normal mitral valves and in chronic valve disease (endocardiosis) in dogs Res Vet Sci 87 2009 277 283
32. E. Rabkin, M. Aikawa, J.R. Stone, Y. Fukumoto, P. Libby, and F.J. Schoen Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodelling in myxomatous heart valves Circulation 104 2001 2525 2532
33. K. Tamura, Y. Fukuda, M. Ishizaki, Y. Masuda, N. Yamanaka, and F.J. Ferrans Abnormalities in elastic fibres and other connective-tissue components of floppy mitral valve Am Heart J 129 1995 1149 1158
34. S. Akhtar, K.M. Meek, and V.J. James Ultrastructure abnormalities in proteoglycans, collagen fibrils, and elastic fibers in normal and myxomatous mitral valve chordae tendineae Cardiovasc Pathol 8 1999 191 201
35. S. Akhtar, K.M. Meek, and V.J. James Immunolocalization of elastin, collagen type I and type III, fibronectin, and vitronectin in extracellular matrix components of normal and myxomatous mitral heart valve chordae tendineae Cardiovasc Pathol 8 4 1999 203 211
36. W.M. Lester Myxomatous mitral valve disease and related entities: the role of matrix in valvular heart disease Cardiovasc Pathol 4 1995 257 264
37. M.J. Davies, B.P. Moore, and M.V. Braimbridge The floppy mitral valve -Study of incidence, pathology, and complications, in surgical, necropsy, and forensic material Br Heart J 40 1978 468 481
38. E. Terzo, M.D. Marcello, H. McAllister, B. Glazier, D. Lo Coco, C. Locatelli, V. Palermo, and P.G. Brambilla Echocardiographic assessment of 537 dogs with mitral valve prolapse and leaflet involvement Vet Radiol Ultrasound 50 2009 416 422
39. R. Tanaka, and Y. Yamane Platelet aggregation in dogs with mitral valve regurgitation Am J Vet Res 61 2000 1248 1251
40. H.D. Pedersen, and J. Häggström Mitral valve prolapsed in the dog: a model of mitral valve prolapse in man Cardiovasc Res 47 2000 234 243
41. L. Agozzino, A. Falco, F. de Vivo, C. de Vincentiis, L. de Luca, S. Esposito, and M. Cotrufo Surgical pathology of the mitral valve: gross and histological study of 1288 surgically excised valves Int J Cardiol 37 1992 79 89
42. D. Pellerin, S. Brecker, and C. Veyrat Degenerative mitral valve disease with emphasis on mitral vlave prolapse Heart 88 Suppl. 4 2002 iv20 iv28
43. M. Prunotto, P.P. Caimmi, and M. Bongiovanni Cellular pathology of mitral valve prolapse Cardiovasc Pathol 19 2010 e113 e117
44. W.C. Roberts, C.L. McIntosh, and R.B. Wallace Mechanisms of severe mitral regurgitation in mitral valve prolapse determined from analysis of operatively excised valves Am Heart J 113 1987 1316 1323
45. W.G. Cole, D. Chan, A.J. Hickey, and D.E.L. Wilcken Collagen composition of normal and myxomatous human mitral valves Biochem J 219 1984 451 460
46. N. Latif, P. Sarathchandra, P.M. Taylor, J. Antoniw, and M.H. Yacoub Localization and pattern of expression of extracellular matrix components in human heart valves J Heart Valve Dis 14 2005 218 227
47. V. Pelouch, I.M.C. Dixon, L. Golfman, R.E. Beamish, and N.S. Dhalla Role of extracellular matrix proteins in heart function Mol Cell Biochem 129 1994 101 120
48. S. Dreger, P.M. Taylor, S.P. Allen, and M.H. Youb Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves J Heart Valve Dis 11 2002 875 880
49. T. Krieg, and E.C. LeRoy Diseases of the extracellular matrix J Mol Med 76 1998 224 225
50. R.R. Souza de Aging of myocardial collagen Biogerontology 3 2002 325 335
51. M. Eghbali, and K.T. Weber Collagen and the myocardium: fibrillary structure, biosynthesis and degradation in relation to hypertrophy and its regression Mol Cell Biochem 96 1990 1 14
52. H. Mollnau, B. Münkel, and J. Schaper Collagen VI in the extracellular matrix of normal and failing human myocardium Herz 20 1995 89 94
53. J.R. Sanes, E. Engvall, R. Butkowski, and D.D. Hunter Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere J Cell Biol 111 1990 1685 1699
54. R.I. Bashey, A. Martinez-Hernandez, and S.A. Jimenez Isolation, characterization, and localization of cardiac collagen VI Circ Res 70 1992 1006 1017
55. H.K. Graham, M. Horn, and A.W. Trafford Extracellular matrix profiles in the progression to heart failure Acta Physiol (Oxf) 194 2008 3 21
56. E. Engvall, H. Hessle, and G. Klier Molecular assembly, secretion, and matrix deposition of type VI collagen J Cell Biol 102 1986 703 710
57. B. Trüeb, T. Schreier, P. Bruckner, and K.H. Winterhalter Type VI collagen represents a major fraction of connective tissue collagens Eur J Biochem 166 1987 699 703
58. S.M. Arribas, A. Hinek, and M.C. Gonzalez Elastic fibres and vascular structure in hypertension Pharmacol Ther 111 2006 771 791
59. B.V. Shekonin, S.P. Domogatsky, G.L. Idelson, and V.E. Koteliansky Participance of fibronectin and various collagen types in the formation of fibrous extracellular matrix in cardiosclerosis J Mol Cell Cardiol 20 1988 501 508
60. B. Speiser, D. Weihrauch, C.F. Riess, and J. Schaper The extracellular matrix in human cardiac tissue part II: vimentin, laminin, and fibronectin Cardioscience 3 1992 41 49
61. G.R. Martin, and R. Timpl Laminin and other basement membrane components Ann Rev Cell Biol 3 1987 57 85
62. J.F. Talts, Z. Andac, W. Gohring, A. Branaccio, and R. Timpl Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins EMBO J 18 1999 863 870
63. R. Stern Association between cancer and "acid mucopolysaccharides": an old concept comes of age, finally Sem Cancer Biol 18 2008 238 243
64. K.S. Kunzelman, R.P. Cochran, S.S. Murphree, W.S. Ring, E.D. Verrier, and R.C. Eberhart Differential collagen distribution in the mitral valve and its influence on biochemical behaviour J Heart Valve Dis 2 1993 236 244
65. J.F. Nasuti, P.J. Zhang, M.D. Feldman, T. Pasha, J.S. Kuhrana, J.H. Gorman, R.C. Gorman, J. Narula, and N. Narula Fibrillin and other matrix proteins in mitral valve prolapse syndrome Ann Thorac Surg 77 2004 532 536
66. M. Hadian, B.M. Corcoran, and J.P. Bradshaw Molecular changes in fibrillar collagen in myxomatous mitral valve disease Cardiovasc Pathol 19 2010 c141 c148
67. M. Hadian, B.M. corcoran, R.I. Han, G. Grossmann, and J.P. Bradshaw Collagen Organization in canine myxomatous mitral valve disease: an X-ray diffraction study Biophysic J 93 2007 2472 2476
68. S.M. Sokkar, and G. Trautwein Die Endokardiose der Atrioventrikularklappen des Hundes. I. Morphologische und histochemische Untersuchungen Zentralbl Vet Med A 17 1970 757 759
69. R.I. Han, A. Black, G.J. Culshaw, A.T. French, R.W. Else, and B.M. Corcoran Distribution of myofibroblasts, smooth muscle like cells, macrophages, and mast cells in mitral valve leaflets of dogs with myxomatous mitral valve disease Am J Vet Res 69 2008 763 769
70. M.J. Glesby, and R.E. Pyeritz Association of mitral valve prolapse and systemic abnormalities of connective tissue. A phenotypic continuum J Am Med Assoc 262 1989 523 528
71. D.M. Milewicz, Z. Urban, and C. Boyd Genetic disorders of the elastic fiber system Matrix Biol 19 2000 471 480
72. Y.Y. Li, C.F. McTiernan, and A.M. Feldman Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling Cardiovasc Res 46 2000 214 224
73. R. Visse, and H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry Circ Res 92 2003 827 839
74. C.M. Dollery, J.R. McEwan, and A.M. Henney Matrix metalloproteinases and cardiovascular disease Circ Res 77 1995 863 868
75. D.L. Mann, and F.G. Spinale Activation of Matrix metalloproteinases in the failing human heart Circulation 98 1998 1699 1702
76. Z. Kassiri, and R. Khokha Myocardial extracellular matrix and its regulation by metalloproteinases and their inhibitors Thromb Haemost 93 2005 212 219
77. A.M. Deschamps, and G. Spinale Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation Cardiovasc Res 69 2006 666 676
78. Y.Y. Li, A.M. Feldman, Y. Sun, and C.F. McTiernan Differential expression of tissue inhibitors of metalloproteinases in the failing human heart Circulation 98 1998 1728 1734
79. O. Fondard, D. Detaint, B. Jung, C. Chouquex, H. Adle-Biassette, M. Jarraya, U. Hvass, J.P. Couetil, D. Henin, J.B. Michel, A. Vahanian, and M.P. Jacob Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors Eur Heart J 26 2005 1333 1341
80. E. Aikawa, P. Whittaker, M. Farber, K. Mendelson, R.F. Padera, M. Aikawa, and F.J. Schoen Human semilunar cardiac valve remodelling by activated cells from fetus to adult: implications for postnatal adaptation, pathology and tissue engineering Circulation 113 2006 1344 1352
81. H. Aupperle, J. Thielebein, B. Kiefer, I. März, G. Dinges, and H.A. Schoon An immunohistochemical study of the role of matrix metalloproteinases and their tissue inhibitors in chronic mitral valvular disease (valvular endocardiosis) in dogs Vet J 180 2009 88 94
82. H. Aupperle, J. Thielebein, B. Kiefer, I. März, G. Dinges, H.A. Schoon, and A. Schubert Expression of genes encoding matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in normal and diseased canine mitral valves J Comp Pathol 140 2009 271 277
83. K. Obayashi, S. Miyagawa-Tomita, H. Matsumoto, H. Koyama, T. Nakanishi, and H. Hirose Effects of transforming growth factor-beta3 and matrix metalloproteinase-3 on the pathogenesis of chronic mitral valvular disease in dogs Am J Vet Res 72 2011 194 202
84. Y. Soini, J. Satta, M. Määttä, and H. Autio-Harmainen Expression of MMP2, MMP9, MTI-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart J Pathol 194 2001 225 231
85. M. Togashi, K. Tamura, T. Nitta, M. Ishizaki, Y. Sugisaki, and Y. Fukuda Role of matrix metalloproteinases and their tissue inhibitor of metalloproteinases in myxomatous change of cardiac floppy valves Pathol Int 57 2007 251 259
86. D. Oceandy, R. Ysoff, F.M. Baudoin, L. Neyses, and S.G. Ray Promoter polymorphism of the matrix metalloproteinase 3 gene is associated with regurgitation and left ventricular remodelling in mitral valve prolapse patients Eur J Heart Fail 9 2007 1010 1017
87. G.J. Koullias, D.P. Korkoli, P. Ravichandran, A. Psyrri, I. Hatzara, and J.A. Elefteriades Tissue microarray detection of matrix metalloproteinases in diseased tricuspid and bicuspid aortic valves with or without pathology of the ascending aorta Eur J Cardiothorac Surg 26 2004 1098 1103
88. P.M. Taylor, P. Batten, N.J. Brand, P.S. Thomas, and M.H. Yacoub The cardiac valve interstitial cell Int J Biochem Cell Biol 35 2003 113 118
89. A. Roy, N.J. Brand, and M.H. Yacoub Molecular characterization of interstitial cells isolated from human heart valves J Heart Valve Dis 9 2000 459 464
90. R.L. Leask, N. Jain, and J. Butany Endothelium and valvular diseases of the heart Microsc Res Tech 60 2003 129 137
91. P.D. Stein, C.H. Wang, J.M. Riddle, H.N. Sabbah, D.J. Magilligan Jr., and E.T. Hawkins Scanning electron microscopy of operative excised severely regurgitant floppy mitral valves Am J Cardiol 64 1989 392 394
92. M. Mirzaie, T. Meyer, P. Schwarz, S. Lofti, A. Rastan, and F. Schondube Ultrastructural alterations in acquired aortic and mitral valve disease as revealed by scanning and transmission electron microscopical investigations Ann Thorac Cardiovasc Surg 8 1 2002 24 30
93. T. Mow, and H.D. Pedersen Increased endothelin-receptor density in myxomatous canine mitral valve leaflets J Cardiovasc Pathol 34 1999 254 260
94. A.M. Muller, C. Cronen, L.I. Kupferwasser, H. Oelert, K.M. Muller, and C.J. Krikpatrick Expression of endothelial cell adhesion molecules on heart valves: up-regulation in degeneration as well as acute endocarditis J Pathol 36 2000 2257 2262
95. M.A. Radermecker, R. Limet, C.M. Lapiere, and B. Nusgens Increased mRNA expression of decorin in the prolapsing posterior leaflet of the mitral valve Interact Cardiovasc Thorac Surg 2 3 2003 389 394
96. S. Disatian, C. Lacerda, and E.C. Orton Tryptophan hydroxylase 1 expression is increased in phenotype-altered canine and human degenerative myxomatous mitral valves J Heart Valve Dis 19 1 2010 71 78
97. R.I. Han, A. Black, G. Culshaw, A.T. French, and B.M. Corcoran Structural and cellular changes in canine myxomatous mitral valve disease: an image analysis study J Heart Valve Dis 19 2010 60 70
98. W. Lars, T. Steffensen, and B. Mats Role of inflammation in nonrheumatic, regurgitant heart valve disease. A comparative, descriptive study regarding apolipoproteins and inflammatory cells in nonrheumatic heart valve disease Cardiovasc Pathol 16 2007 171 178
99. P.J. Barth, H. Koster, and R. Moosdorf CD34+ fibrocytes in normal mitral valves and myxomatous mitral valve degeneration Pathol Res Pract 201 2005 301 304
100. A.C. Liu, V.R. Joag, and A.I. Gotlieb The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology Am J Pathol 171 5 2007 1407 1417
101. F.C. Caira, S.R. Stock, T.G. Gleason, E.C. McGee, J. Huang, R.O. Bonow, T.C. Spelsberg, P.M. McCathy, S.H. Rachimtoola, and N.M. Rajamannan Human degenerative valve disease is associated with up-regulation of low density lipoprotein receptor-related protein 5 receptor mediated bone formation J Am Coll Cardiol 47 8 2006 1707 1712
102. E.R. Mohler, F. Gannon, C. Reynolds, R. Zimmerman, M.G. Keene, and F.S. Kaplan Bone formation and inflammation in cardiac valves Circulation 103 2001 1522 1528
103. MacLea HB, Lacerda C, Kisiday JD, Orton EC. Canine and Human Degenerative mitral valve disease mimics chondrogenesis. 2011; 25:632-676 (research abstract).
104. S.W. MacMahon, J.K. Roberts, R. Kramer-Fox, D.M. Zucker, R.B. Roberts, and R.B. Devereux Mitral valve prolapse and infective endocarditis Am Heart J 113 1987 1291 1298
105. A. Pomerance, and J. Whitney Heart valve changes common to man and comparative study Cardiovasc Res 4 1970 61 66
106. V.P. Vienot Pathology of inflammatory native valvular heart disease Cardiovasc Pathol 15 2006 243 251
107. T. Tomaru, Y. Uchida, N. Mohri, W. Mori, A. Furuse, and K. Asano Postinflammatory mitral and aortic valve prolapsed: a clinical and pathological study Circulation 114 1 1987 63 69
108. J.H. Park, H.J. Youn, J.S. Yoon, C.S. Park, S.S. Oh, W.B. Chung, J.W. Chung, Y.S. Choi, D.H. Lee, Y.S. Oh, W.S. Chung, S.J. Hong, Y.S. Lee, S.B. Sim, and S.H. Lee The expression of transforming growth factor β1 and α-smooth muscle actin is increased in the human myxomatous valve Korean J Pathol 43 2009 152 156
109. S. Disatian, and E.C. Orton Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease J Heart Valve Dis 19 1 2009 71 78
110. S.M. Scruggs, S. Disatian, and E.C. Orton Serotonin transmembrane transporter is down-regulated in late-stage canine degenerative mitral valve disease J Vet Cardiol 12 3 2010 163 169